• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kanao Kent  金尾 健人

ORCIDConnect your ORCID iD *help
Researcher Number 20327620
Other IDs
Affiliation (Current) 2025: 藤田医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help 2019 – 2023: 埼玉医科大学, 医学部, 准教授
2018: 愛知医科大学, 医学部, 講師
Review Section/Research Field
Principal Investigator
Basic Section 56030:Urology-related / Basic Section 50010:Tumor biology-related
Keywords
Principal Investigator
進行腎癌一次治療 / バイオマーカー / 制御性T細胞 / 腎癌 / 前立腺癌 / リンパ節転移 / microRNA / エクソソーム / 前転移ニッチ
  • Research Projects

    (2 results)
  • Research Products

    (3 results)
  • Co-Researchers

    (3 People)
  •  制御性T細胞の機能に着目した進行腎癌一次治療の選択に有用なバイオマーカーの 探索Principal Investigator

    • Principal Investigator
      金尾 健人
    • Project Period (FY)
      2022 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Saitama Medical University
  •  Exploratory research of microRNA related to pre-metastatic lymph node niche formation in prostate cancer.Principal Investigator

    • Principal Investigator
      Kanao Kent
    • Project Period (FY)
      2018 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50010:Tumor biology-related
    • Research Institution
      Saitama Medical University
      Aichi Medical University

All 2021 2019

All Journal Article

  • [Journal Article] Safety of adjuvant gemcitabine plus cisplatin chemotherapy in a patient with bilateral ureteral cancer undergoing hemodialysis2021

    • Author(s)
      Goto Yumiko、Kanao Kent、Matsumoto Kazuhiro、Kobayashi Ikuo、Kajikawa Keishi、Onishi Masafumi
    • Journal Title

      International Cancer Conference Journal

      Volume: 10 Issue: 3 Pages: 212-216

    • DOI

      10.1007/s13691-021-00483-1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K07210
  • [Journal Article] Prostate-specific Antigen Response Patterns During Cabazitaxel Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer2019

    • Author(s)
      Kent Kanao, Toshiki Ito, Kiyoshi Takahara, Ryosuke Ando, Takahiro Yasui, Ryoichi Shiroki, Hideaki Miyake, Makoto Sumitomo
    • Journal Title

      Jpn J Clin Oncol

      Volume: 49 Issue: 11 Pages: 1043-1048

    • DOI

      10.1093/jjco/hyz110

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18K07210
  • [Journal Article] Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.2019

    • Author(s)
      Watanabe M, Kanao K, Suzuki S, Muramatsu H, Morinaga S, Kajikawa K, Kobayashi I, Nishikawa G, Kato Y, Zennami K, Nakamura K, Tsuzuki T, Yoshikawa K, Ueda R, Sumitomo M.
    • Journal Title

      Prostate

      Volume: 79(14) Issue: 14 Pages: 1658-1665

    • DOI

      10.1002/pros.23890

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11163, KAKENHI-PROJECT-18K07210, KAKENHI-PROJECT-18K07277, KAKENHI-PROJECT-18K16715, KAKENHI-PROJECT-17K11301
  • 1.  都築 豊徳 (70627645)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 2.  鈴木 進 (70518422)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  SUMITOMO Makoto
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi